OR WAIT 15 SECS
© 2021 MJH Life Sciences and Pharmaceutical Technology. All rights reserved.
© 2021 MJH Life Sciences™ and Pharmaceutical Technology. All rights reserved.
February 03, 2021
Plasma-based proteins and cell-based therapies have significant potential to address unmet medical needs.
Rapid growth in biologics and increasing complexity of new compounds are some of the factors driving development of innovative delivery solutions.
Viewpoint: Continued dialogue among pharma stakeholders is needed to achieve consensus regarding excipient composition.
January 03, 2021
The right partner can help companies overcome key formulation challenges for biologic drugs.
December 16, 2020
A newly developed polymer, DynaShield, may have the capability to ensure global access for COVID-19 treatment and prevention.
December 10, 2020
Evonik offers lipid nanoparticles for gene-based drug development and manufacturing.
December 08, 2020
A development agreement will study inhaled formulations of cannabinoid-based drug product for central nervous system diseases.
December 03, 2020
Operator, caregiver, and patient safety are at the forefront when selecting the best options and dosage forms.
Study results indicate that fatty alcohols may plausibly enhance the skin permeation of clotrimazole.
November 04, 2020
At the 2020 Bio/Pharma Virtual Congress, experts discuss the importance of characterizing excipients to ensure quality, safety, and effective performance.
November 03, 2020
This paper reviews considerations for the formulation of chewable tablets including sensory characteristics, chewability assessment, and drug release.
Amorphous solid dispersions are a useful tool in overcoming solubility issues, but they have not yet reached full potential in commercial success.
October 15, 2020
The IQ Consortium marks a decade of impactful innovation of collaboration through a network of pharmaceutical companies driving change for the bio/pharmaceutical industry.
October 03, 2020
More complex and challenging compounds require a more tailored approach to formulation strategies.
Taste-masking can be of significant importance in ensuring success of a drug product, particularly those targeted to pediatric or geriatric populations.
Excipients must be carefully chosen to ensure optimum protection for vaccines and live biotherapeutic products.
September 03, 2020
Tight development timelines and accelerated approval pathways favor simple, cost-effective capsule formulations.
September 02, 2020
End-user considerations are becoming increasingly important as they can provide a lot of value and help to ensure commercial success of a drug.
August 03, 2020
This study suggests that using a simple centrifugal method can produce a natural polymer-blend molecule that can successfully be used as an oral delivery mechanism for poorly soluble drugs.
Particle engineering is a useful tool to manipulate API particles into a form that is manufacturable and deliverable to the patient.